首页|《IASLC第九版肺癌TNM分期》解读

《IASLC第九版肺癌TNM分期》解读

扫码查看
国际肺癌研究协会(International Association for the Study of Lung Cancer,IASLC)于近期正式发布了第九版肺癌TNM分期.本次分期基于全新的数据库,涵盖2011-2019年间25个国家75个中心的124 581例肺癌患者的数据,在排除数据不完整的患者后,共纳入87 043例患者的资料,并基于此分析结果,对第八版肺癌TNM分期进行调整,更新成第九版肺癌TNM分期.此版中亚洲患者占比提升,中国患者占比增幅显著.第九版肺癌TNM分期将为肺癌诊治及预后评估提供更合理的参考依据.本文就IASLC第九版肺癌TNM分期标准的数据库更新、分期变化及其修订依据进行解读,为广大临床医生提供参考.
Interpretation of the IASLC ninth edition of the TNM classification for lung cancer
The International Association for the Study of Lung Cancer(IASLC)recently introduced the ninth edition of the TNM classification for lung cancer.This milestone is supported by a comprehensive database comprising 124 581 lung cancer patients from 75 centers across 25 nations between 2011 and 2019.Following the exclusion of incomplete data,the analysis focused on 87 043 patients.These insights guided the modifications in the ninth edition of the TNM classification for lung cancer.The updated classification nowincludes a higher representation of Asian patients,particularly showing significant growth among Chinese patients.This revised classification will offer more pertinent benchmarks for the diagnosis and prognostic assessment oflung cancer.This article delves into the database updates,stage adjustments,and rationale behind the IASLC ninth edition of the TNM classification forlung cancer.

Lung cancerTNM classificationninth editioninterpretation

赵珂嘉、刘成武、刘伦旭

展开 >

四川大学华西医院胸外科(成都 610041)

肺癌 TNM分期 第九版 解读

2024

中国胸心血管外科临床杂志
四川大学华西医院

中国胸心血管外科临床杂志

CSTPCD北大核心
影响因子:0.846
ISSN:1007-4848
年,卷(期):2024.31(4)
  • 21